The National Health and Medical Research Council approved Clinical Guidelines for Prevention, Early Detection and Management of Colorectal Cancer (2017) provide evidence-based recommendations and clinical guidance across the continuum of bowel cancer care including prevention, screening and diagnosis, clinical aspects of treatment, follow-up and psychosocial care. The guidelines also provide an evidence base for the National Bowel Cancer Screening Program.
The New NHMRC approved Guidelines and what they mean for the National Bowel Cancer Screening Program fact sheet provides a brief overview of the key guideline changes that relate to the National Bowel Cancer Screening Program.
PDF version: New NHMRC approved Guidelines and what they mean for the National Bowel Cancer Screening Program (PDF 171 KB)
Word version: New NHMRC approved Guidelines and what they mean for the National Bowel Cancer Screening Program (Word 1915 KB)
The 2011 Clinical Practice Guidelines for Surveillance Colonoscopy focus on the appropriate use of colonoscopy in colorectal cancer prevention and are also under review, it is anticipated that the revised guidelines will be published in 2018.
Other guidelines, policies and evidence reviews
The Royal Australian College of General Practitioners’ Guidelines for preventive activities in general practice provides guidance on bowel cancer screening.
The Cancer Council Australia’s National Cancer Control Policy: Bowel Screening provides evidence on why the iFOBT is the recommended screening tool for bowel cancer.
HealthPACT report - Blood and stool biomarker testing for colorectal cancer screening - August 2016 - an assessment which compared the iFOBT used in the Australian NBCSP (from 2006 - 2017) with other blood-based biomarker and stool-based tests for the detection of colorectal cancer. There is a lack of evidence to support the use of these tests to detect early adenomas.